All News Dicot AB

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-05 EDT			5-day change	1st Jan Change
0.254 ^SEK	-5.22%		+6.72%	-20.13%

05-06	Dicot AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-23	Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	CI

Dicot presents interim report Q1 2024	05-06	AQ
Dicot AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-06	CI
Good safety and improved erectile function reported from Dicot's phase 1 study	04-23	AQ
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	04-23	CI
Dicot in preparation for clinical phase 2a trial	04-12	AQ
Reporting from Dicot's phase 1 study end of April	04-05	AQ
BioStock: Dicot's phase I study fully recruited	03-14	AQ
Recruitment completed in Dicot's phase 1 trial	03-11	AQ
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	03-11	CI
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	02-29	AQ
Dicot AB Year-End Report 2023	02-26	AQ
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-26	CI
BioStock: Good safety profile for Dicot's LIB-01	01-26	AQ
Positive results from the first part of Dicot's phase 1 study	01-23	AQ
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	01-23	CI
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	01-11	MT
Dicot applies for patent covering new manufacturing technology	01-11	AQ
Dicot Applies for Patent Covering New Manufacturing Technology	01-11	CI
Dicot invited to present at ESSM for the third time	01-05	AQ
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	12-20	AQ

No results for this search